Welcome and thank you for visiting Biocure Technology Inc.
We are a publicly trading company on the Canadian Securities Exchange CSE:CURE.
Our team of four highly-skilled researchers have over 95 years of combined experience and expertise in the production of various biopharmaceutical. Biocure is also collaborating with several universities and hospitals in South Korea to continue the advanced development of several technologies.
Biocure’s mission is to continue to advance the research and development of our biopharmaceuticals products in the most ethical and cost-effective manner as possible. With our experience of our team of professionals and collaborations we aim to launch our products to the market as soon as possible. The current order of business categories are: Biosimilar / CAR T Cell / Hair Growth Factor.
CURE.CN 0,80 -0,02 -2,44%